Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer (STAR-BREAST)

NCT07070128 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07070128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07070128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer (STAR-BREAST)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
August 20, 2025
Completion date
August 11, 2026
Enrollment
800 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms